Tag: duchenne muscular dystrophy (dmd) therapeutics market share

  • Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

    Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Projected to Reach $47.74 Billion by 2029 at a CAGR of 30.7%

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Are the Projected Market Size and Growth Rates for the Duchenne Muscular Dystrophy (DMD) Therapeutics Market From 2025 To 2029?

    In recent times, the market size for duchenne muscular dystrophy (DMD) therapeutics has seen a significant expansion. The market is projected to surge from $11.95 billion in 2024 to $16.38 billion in 2025, with a compound annual growth rate (CAGR) of 37.0%. Factors contributing to the stellar growth in the historic period include the rising incidence of duchenne muscular dystrophy, elevated awareness about its treatment, increased expenditure on healthcare, and government-led initiatives.

    In the forthcoming years, a substantial upswing is expected in the market size of Duchenne Muscular Dystrophy (DMD) therapeutics, which is projected to reach $47.74 billion by 2029, driven by a CAGR of 30.7%. Multiple factors can be credited for this expansion over the forecast period, including the increase in funding for DMD treatments, the practice of combined therapies, the rise of biomarkers, and a growing amount of screening programs for DMD. Furthermore, the prediction period will also see several significant trends like innovative DMD treatments, the creation of targeted therapies, the launch of new medications and therapies, inventive disease-altering therapies, and ongoing drug developments.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12916&type=smp

    What are the Fundamental Drivers and Innovations Shaping the Duchenne Muscular Dystrophy (DMD) Therapeutics Market?

    The uptick in clinical trials is projected to drive Duchenne muscular dystrophy (DMD) therapeutics market expansion. These are research projects undertaken on human subjects to ascertain the potential benefits, safety, and efficiency of newly developed medical interventions or drugs. The rise in clinical trials centred on Duchenne muscular dystrophy therapies underscores the relentless pursuit of research, innovation, and a broad spectrum of therapeutic options. Collectively, these factors are likely to improve patient prospects, entice investments and fast-track the progress and availability of effective treatments for Duchenne Muscular Dystrophy (DMD). For instance, in August 2023, as per data from Clinicaltrials.Gov, an offshoot of The National Institutes Of Health (NIH), a U.S. government body in charge of directing and backing medical research, the tally of registered clinical trials escalated to 464,218, a rise from 399,496 in 2021. This increase occurred across all 50 states of the U.S. and in 221 different countries. Additionally, it was disclosed that 142,700 studies, or 31% of the total, were registered in the U.S., and 248,310 studies, or 53% of all total studies, were documented in non-U.S. locations. Consequently, the upswing in the count of clinical trials is set to push the Duchenne muscular dystrophy (DMD) therapeutics market’s growth.

    How Is the Duchenne Muscular Dystrophy (DMD) Therapeutics Market Segmented?

    The duchenne muscular dystrophy (dmd) therapeutics market covered in this report is segmented –

    1) By Type: Small Molecules, Biologics

    2) By Distribution Channel: Offline, Online

    3) By Application: Hospitals, Clinics, Home Care

    Subsegments:

    1) By Small Molecules: Exon Skipping Therapies, Antisense Oligonucleotides, Read-Through Compounds

    2) By Biologics: Gene Therapies, Cell Therapies, Protein Replacement Therapies

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=12916&type=smp

    Which Regions Are Driving the Next Phase of the Duchenne Muscular Dystrophy (DMD) Therapeutics Market Growth?

    North America was the largest region in the DMD therapeutics market in 2024. The regions covered in duchenne muscular dystrophy (DMD) therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    What Key Trends Are Shaping the Future of the Duchenne Muscular Dystrophy (DMD) Therapeutics Market?

    Prominent firms in the Duchenne muscular dystrophy (DMD) therapeutics market are leveraging advanced technologies to increase the effectiveness and availability of DMD treatments in order to maintain their market prominence. In example, Bit Bio Ltd., a synthetic biology corporation based in the UK, unveiled disease model products in July 2023 to expedite DMD treatment advancements. These disease models, titled ioSkeletal Myocytes DMD Exon 44 Deletion and ioSkeletal Myocytes DMD Exon 52 Deletion, are human skeletal myocytes imbued with genetically engineered deletions in the dystrophin-producing gene. Bit. Bio’s models, derived from induced pluripotent stem cells (iPSCs), deliver a reliable and expandable source of human cells for research, tackling hurdles related to variability and primary cell sourcing. The models expedite DMD treatments’ development by offering insights into disease processes and potential treatment options, potentially fast-tracking researchers’ efforts to find effective DMD treatments.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/duchenne-muscular-dystrophy-dmd-therapeutics-global-market-report

    How Is the Duchenne Muscular Dystrophy (DMD) Therapeutics Market Defined and What Are Its Core Parameters?

    Duchenne muscular dystrophy (DMD) therapeutics refers to the various medical treatments and interventions aimed at managing and alleviating the symptoms of duchenne muscular dystrophy, a genetic disorder characterized by progressive muscle weakness and degeneration. These therapeutic approaches are designed to slow disease progression, improve muscle function and enhance the overall quality of life for individuals with duchenne muscular dystrophy.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12916

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Key Insights into the Duchenne Muscular Dystrophy (DMD) Therapeutics Market’s Growth Opportunities for 2024-2033

    Key Insights into the Duchenne Muscular Dystrophy (DMD) Therapeutics Market’s Growth Opportunities for 2024-2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Duchenne Muscular Dystrophy (DMD) Therapeutics Market from 2024 to 2033?

    The Duchenne muscular dystrophy (DMD) therapeutics market has grown exponentially in recent years. It will increase from $8.64 billion in 2023 to $11.95 billion in 2024, at a compound annual growth rate (CAGR) of 38.4%. The growth is attributed to the rising prevalence of DMD, greater awareness about its treatment, increasing healthcare spending, and government initiatives.

    The Duchenne muscular dystrophy (DMD) therapeutics market is expected to see exponential growth, reaching $36.72 billion by 2028, with a CAGR of 32.4%. Growth is driven by growing investments, the adoption of combination therapies, the emergence of biomarkers, and the increase in screening programs. Key trends include innovative treatments, targeted therapies, novel medications, and disease-modifying therapies.

    Claim Your Free Sample of the Global Duchenne Muscular Dystrophy (DMD) Therapeutics Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12916&type=smp

    The rising number of clinical trials is anticipated to propel the Duchenne muscular dystrophy (DMD) therapeutics market. The surge in trials highlights ongoing research and development, which could lead to better treatments and outcomes for DMD patients. As of August 2023, the number of registered clinical trials globally had increased to 464,218, up from 399,496 in 2021, as reported by Clinicaltrials.Gov. This growth in clinical trials is a major driver for the DMD therapeutics market.

    1) By Type: Small Molecules, Biologics

    2) By Distribution Channel: Offline, Online

    3) By Application: Hospitals, Clinics, Home Care

    Companies in the Duchenne muscular dystrophy (DMD) therapeutics market are advancing treatment options using new technologies. In July 2023, Bit Bio Ltd. launched ioSkeletal Myocytes DMD Exon 44 and Exon 52 Deletion models. These human skeletal myocytes, engineered from induced pluripotent stem cells (iPSCs), offer consistent and scalable research sources for DMD treatments, potentially accelerating the development of effective therapies.

    Order Now for Fast Delivery of Your Duchenne Muscular Dystrophy (DMD) Therapeutics Market Report!

    https://www.thebusinessresearchcompany.com/report/duchenne-muscular-dystrophy-dmd-therapeutics-global-market-report

    North America was the largest region in the seborrheic dermatitis market in 2023. The regions covered in the seborrheic dermatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Duchenne Muscular Dystrophy (DMD) Therapeutics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the duchenne muscular dystrophy (dmd) therapeutics market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Duchenne Muscular Dystrophy (DMD) Therapeutics Market Include
    1. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Executive Summary
    2. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Segments
    3. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Size And Template Market Growth Rate
    4. Key Duchenne Muscular Dystrophy (DMD) Therapeutics Market Trends
    5. Major Duchenne Muscular Dystrophy (DMD) Therapeutics Market Drivers
    ……
    25. Key Mergers And Acquisitions In The Duchenne Muscular Dystrophy (DMD) Therapeutics Market
    26. Top Duchenne Muscular Dystrophy (DMD) Therapeutics Companies
    27. Duchenne Muscular Dystrophy (DMD) Therapeutics Market Opportunities And Strategies
    28. Duchenne Muscular Dystrophy (DMD) Therapeutics Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:

    Macular Degeneration Treatment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/macular-degeneration-treatment-global-market-report

    Age-Related Macular Degeneration Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/age-related-macular-degeneration-global-market-report

    Duchenne Muscular Dystrophy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/duchenne-muscular-dystrophy-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: